| Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979) |
|---|
| 08/07/2001 | US6271236 Diaminopyridine-containing thiourea inhibitors of herpes virus |
| 08/07/2001 | US6271235 HIV protease inhibitors |
| 08/07/2001 | US6271179 Herbicides |
| 08/07/2001 | US6271178 Substituted 2,4-diamino-1,3,5-triazine as herbicide |
| 08/07/2001 | CA2242242C Quinolonecarboxylic acid derivatives or salts thereof |
| 08/07/2001 | CA2213197C Certain bridged 4-phenyl-2-aminomethylimidazoles; new dopamine receptor subtype specific ligands |
| 08/07/2001 | CA2030051C Indole derivatives |
| 08/07/2001 | CA2020133C Novel dihydropiridines comprising sterically hindered groups |
| 08/04/2001 | CA2646796A1 Hydroxypyridine compounds useful as intermediates |
| 08/02/2001 | WO2001055146A1 FACTOR Xa INHIBITORS WITH ARYL-AMIDINES AND DERIVATIVES, AND PRODRUGS THEREOF |
| 08/02/2001 | WO2001055132A1 1,3-disubstituted pyrrolidines as alpha-2-adrenoceptor antagonists |
| 08/02/2001 | WO2001055123A1 Nitrogen-containing 5-membered cyclic compounds and drugs containing these compounds as the active ingredient |
| 08/02/2001 | WO2001055119A2 Gonadotropin-releasing hormone receptor antagonists and methods relating thereto |
| 08/02/2001 | WO2001055116A2 Quinoline derivatives and their use as aurora 2 kinase inhibitors |
| 08/02/2001 | WO2001055115A1 Substituted nicotinamides and analogs as activators of caspases and inducers of apoptosis and the use thereof |
| 08/02/2001 | WO2001055114A1 2-amino-nicotinamide derivatives and their use as vegf-receptor tyrosine kinase inhibitors |
| 08/02/2001 | WO2001055112A1 Method for preparing alpha-sulfonyl hydroxamic acid derivatives |
| 08/02/2001 | WO2001055111A1 Biaryl compounds, their preparation and their use in therapy |
| 08/02/2001 | WO2001055110A1 Isatine derivatives with neurotrophic activity |
| 08/02/2001 | WO2001055109A1 Aromatic amides acting on melanocortin receptors |
| 08/02/2001 | WO2001055106A2 Novel melanocortin receptor agonists and antagonists |
| 08/02/2001 | WO2001055105A1 N-substituted 2-cyanopyroles and -pyrrolines which are inhibitors of the enzyme dpp-iv |
| 08/02/2001 | WO2001055082A2 Intermediates for biologically active compounds |
| 08/02/2001 | WO2001054694A1 Tetrahydropyrimidone inhibitors of fatty acid binding protein and method |
| 08/02/2001 | WO2001054501A2 Herbicidal composition |
| 08/02/2001 | WO2001054481A2 Enhanced propertied pharmaceuticals |
| 08/02/2001 | WO2001014330A3 Phenylpiperazines as serotonin reuptake inhibitors |
| 08/02/2001 | WO2001012189A8 3(5)-amino-pyrazole derivatives, process for their preparation and their use as antitumor agents |
| 08/02/2001 | WO2000076971A3 Serine protease inhibitors |
| 08/02/2001 | WO2000067847A3 Use of dopamine d3 receptor ligands for producing medicaments for treating kidney disorders |
| 08/02/2001 | WO2000067801A3 Prodrugs of chemotherapeutic agents with oxaalkanoic acids |
| 08/02/2001 | US20010011136 Anticancer agents |
| 08/02/2001 | US20010011135 Anticancer agents |
| 08/02/2001 | US20010011094 HIV inhibiting pyrimidine derivatives |
| 08/02/2001 | US20010011093 Arylgycinamide derivatives, methods of producing these substances and pharmaceutical compositions containing such compounds |
| 08/02/2001 | US20010011092 High affinity ligands for nociceptin receptor ORL-1 |
| 08/02/2001 | US20010011091 Pyrrolidinyl and pyrrolinyl ethylamine compounds as kappa agonists |
| 08/02/2001 | US20010011090 Calciumm channel blockers; therapy for asthma, arthritis |
| 08/02/2001 | US20010011089 Substituted oximes and hydrazones as neurokinin antagonists |
| 08/02/2001 | CA2398728A1 Novel melanocortin receptor agonists and antagonists |
| 08/02/2001 | CA2398561A1 Method for preparing alpha-sulfonyl hydroxamic acid derivatives |
| 08/02/2001 | CA2397831A1 Enhanced propertied pharmaceuticals |
| 08/02/2001 | CA2397493A1 Substituted nicotinamides and analogs as activators of caspases and inducers of apoptosis and the use thereof |
| 08/02/2001 | CA2396596A1 Tetrahydropyrimidone inhibitors of fatty acid binding protein and method |
| 08/02/2001 | CA2394292A1 Isatine derivatives with neurotrophic activity |
| 08/01/2001 | EP1120414A1 Disubstituted maleimide compounds and medicinal utilization thereof |
| 08/01/2001 | EP1120410A1 Nicotinic acid esters useful as CNS agents and having affinity for 5-HT receptors |
| 08/01/2001 | EP1120409A1 2,3-disubstituted pyridine derivatives, process for the preparation thereof, drug compositions containing the same and intermediates for the preparation |
| 08/01/2001 | EP1119567A1 Quinazoline derivatives |
| 08/01/2001 | EP1119566A1 Novel heterocyclyl-methyl-substituted pyrazoles |
| 08/01/2001 | EP1119565A1 Cytotoxic alkaloids (halitulin) |
| 08/01/2001 | EP1119564A1 Aryl- 4-fluoro-4- (2-pyridin-2-yl-ethylamino)-methyl]-piperidin-1-yl -methanone derivatives as 5-ht1 receptor antagonists |
| 08/01/2001 | EP1119563A1 Tetrahydrobenzazepine derivatives useful as modulators of dopamine d3 receptors (antipsychotic agents) |
| 08/01/2001 | EP1119562A1 2,3-dihydro-1h-isoindole derivatives useful as modulators of dopamine d3 receptors (antipsychotic agents) |
| 08/01/2001 | EP1119552A1 Ureidopiperidine derivatives as selective human nk 3? receptor antagonists |
| 08/01/2001 | EP1119551A1 Naphthalenecarboxamides as tachykinin receptor antagonists |
| 08/01/2001 | EP1119548A1 Pyrrole-2,5-diones as gsk-3 inhibitors |
| 08/01/2001 | EP1119547A1 Substituted pyrrolidinone, thiazolidinone or oxazolidinone as herbicides |
| 08/01/2001 | EP1119356A1 Radiolabeled neurokinin-1 receptor antagonists |
| 08/01/2001 | EP1119355A1 Naphthalenecarboxamides as tachykinin receptor antagonists |
| 08/01/2001 | EP1119354A1 Peripherally acting anti-pruritic opiates |
| 08/01/2001 | EP0877737B1 Novel n-(arylsulphonyl)amino acid derivatives having bradykinin receptor affinity |
| 08/01/2001 | EP0862567B1 5-azabicyclo(3.1.0)hexylalkyl-2-piperidones and -glutarimides as neurokinin receptor antagonists |
| 08/01/2001 | CN1306528A Immuno-modulator exhibiting anti-microbial and anti-mycobacterial activities, its prodn. method and applications |
| 08/01/2001 | CN1306526A Novel heterocyclically substituted amides with cysteine protease-inhibiting effect |
| 08/01/2001 | CN1306525A Carboxylic acid of aza-heterocyclic compounds contg. multiple hetero-atoms or its electronic isosteric object |
| 08/01/2001 | CN1306516A Dihydrotriazolone derivatives as pesticides |
| 08/01/2001 | CN1306512A Heterocyclic inhibitors of P38 |
| 08/01/2001 | CN1306511A Novel heterocyclic compounds |
| 08/01/2001 | CN1305993A Cyclic guanyl preparation used as nitrogen oxide synthetic enzyme inhibitor |
| 08/01/2001 | CN1305989A Benzene sulfonamide compounds, its preparing method and medicinal compsns. contg. same |
| 08/01/2001 | CN1305812A N-(aryloxy group alkyl) heteroaromatic guadine and heteroaromatic guazine used as medicines |
| 07/31/2001 | USRE37303 Administering to warm-blooded animals imidazole derivative for inducing antagonist activity of h.sub.3 histamine receptors |
| 07/31/2001 | US6268509 Parasiticidal pyrazoles |
| 07/31/2001 | US6268505 2-(2′Hydroxyphenyl) benzotriazoles and process for their preparation |
| 07/31/2001 | US6268502 Process of synthesis of 5-methoxy- 2-[(4-methoxy-3,5-dimethy-2-pyridyl)methyl]sulfiny-1h-benzimidazole |
| 07/31/2001 | US6268391 Benzylidene-1,3-dihydro-indol-2-one derivatives a receptor tyrosine kinase inhibitors, particularly of Raf kinases |
| 07/31/2001 | US6268385 Dry blend pharmaceutical formulations |
| 07/31/2001 | US6268384 Compounds possessing neuronal activity |
| 07/31/2001 | US6268382 Methods and compositions for treating allergic disorders and other disorders using norastemizole in combination with other active ingredients |
| 07/31/2001 | US6268380 E.g., ethyl beta-((n-3(((4(aminoiminomethyl)phenyl)amino)carbonyl)piperidy lcarbonyl)amino)-3-pyridinepropanoate |
| 07/31/2001 | US6268379 Substituted aryl hydroxamic acids as metalloproteinase inhibitors |
| 07/31/2001 | US6268378 Integrin receptor antagonists |
| 07/31/2001 | US6268370 Compounds |
| 07/31/2001 | US6268369 5-(heterocyclic alkyl)-6-aryl-dihydropyrimidines |
| 07/31/2001 | US6268365 Src family SH2 domain inhibitors |
| 07/31/2001 | US6268363 Antitumor |
| 07/31/2001 | US6268163 Identification of drug candidates modulating factor VII-mediated intracellular signaling |
| 07/31/2001 | CA2282890C Therapeutic heterocyclic compounds |
| 07/31/2001 | CA2040774C Compounds formed from o-hydroxyphenyl-1,3,5-triazines and sterically hindered amines |
| 07/26/2001 | WO2001053297A1 Alpha v integrin receptor antagonists |
| 07/26/2001 | WO2001053296A1 Method for producing heterocyclic compounds |
| 07/26/2001 | WO2001053289A1 Anticancer compound and enantiomer separation method useful for synthesizing said compound |
| 07/26/2001 | WO2001053288A1 Novel piperidine compounds and drugs containing the same |
| 07/26/2001 | WO2001053274A1 Amide compounds for inhibiting protein kinases |
| 07/26/2001 | WO2001053273A1 3-aminoquinazolin-2,4-dione antibacterial agents |
| 07/26/2001 | WO2001053271A1 Imidazole compounds and their use as adenosine deaminase inhibitors |
| 07/26/2001 | WO2001053268A2 Indazole compounds, pharmaceutical compositions, and their use for mediating or inhibiting cell proliferation |
| 07/26/2001 | WO2001053263A1 Corticotropin releasing factor antagonists |
| 07/26/2001 | WO2001053262A1 Alpha v integrin receptor antagonists |